Drug Shortage Report for INDIUM (111IN) OXINE SOLUTION
| Report ID | 273147 |
| Drug Identification Number | 02329026 |
| Brand name | INDIUM (111IN) OXINE SOLUTION |
| Common or Proper name | indium (111) oxine solution |
| Company Name | GE HEALTHCARE CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | INDIUM OXINE |
| Strength(s) | 37MBq |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 mL |
| ATC code | V09HB |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2025-12-04 |
| Estimated end date | 2025-12-10 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-12-05 |
| Company comments | Reason for shortage: equipment failure |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
| Company contact information | 800-387-7146 canadainfo@gehealthcare.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-12-05 | English | Compare |
| v2 | 2025-12-04 | French | Compare |
| v1 | 2025-12-04 | English | Compare |
Showing 1 to 3 of 3